How can the varied tumour FFPE blocks with HER2 ultra-low influenced on the accurate diagnosis of HER2 in breast cancer

被引：0
|
作者：
Liu, Y. [1 ]
Li, J. [1 ]
Liu, H. [1 ]
Ding, Y. [1 ]
Wu, S. [1 ]
Shang, J. [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-01-001
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Chen, Zhaoxu
    Jia, Huiqing
    Zhang, Huina
    Chen, Lifang
    Zhao, Peng
    Zhao, Jing
    Fu, Guangming
    Xing, Xiaoming
    Li, Yujun
    Wang, Chengqin
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (02) : 313 - 323
  • [2] Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
    Zhaoxu Chen
    Huiqing Jia
    Huina Zhang
    Lifang Chen
    Peng Zhao
    Jing Zhao
    Guangming Fu
    Xiaoming Xing
    Yujun Li
    Chengqin Wang
    Breast Cancer Research and Treatment, 2023, 202 : 313 - 323
  • [3] Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2
    Ahuja, Sana
    Khan, Adil Aziz
    Zaheer, Sufian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [4] HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
    Venetis, Konstantinos
    Crimini, Edoardo
    Sajjadi, Elham
    Corti, Chiara
    Guerini-Rocco, Elena
    Viale, Giuseppe
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Fusco, Nicola
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [5] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Yuefeng Wang
    Julia Y. S. Tsang
    Yongmei Cui
    Ji Cui
    Ying Lin
    Songli Zhao
    Patrick T. W. Law
    Sai Yin Cheung
    Enders K. O. Ng
    Gary M. K. Tse
    Zunfu Ke
    Scientific Reports, 7
  • [6] Sensitivity analysis of different HER2 clone numbers for detecting HER2 low and ultra-low expression in invasive breast cancer
    Liu, Y.
    Shang, J.
    He, J.
    Ding, Y.
    Li, J.
    VIRCHOWS ARCHIV, 2024, 485 : S197 - S198
  • [7] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Wang, Yuefeng
    Tsang, Julia Y. S.
    Cui, Yongmei
    Cui, Ji
    Lin, Ying
    Zhao, Songli
    Law, Patrick T. W.
    Cheung, Sai Yin
    Ng, Enders K. O.
    Tse, Gary M. K.
    Ke, Zunfu
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Analysis of the Impact of Varied Tumor FFPE Blocks on the Diagnosis of HER2 IHC 0, Ultralow and 1+in Breast Cancer
    Liu, Hongbo
    Wu, Si
    Liu, Yueping
    LABORATORY INVESTIGATION, 2024, 104 (03) : S214 - S215
  • [9] Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 "Ultra-Low" Setting: Implications for Precision Therapy in HER2-Breast Cancer
    Petricoin, Emanuel F.
    Corgiat, Brian A.
    O'Shaughnessy, Joyce
    LoRusso, Patricia
    Weinberg, Kris
    Davis, Justin
    Gawryletz, Chelsea
    CANCER RESEARCH, 2023, 83 (05)
  • [10] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
12345